Methycobal Injection - Administration Guide

What is Methycobal Injection?

Routes of Administration

• Intramuscular (IM) - most common and preferred route
• Intravenous (IV) - also stated on the Methycobal label (used in some Asian markets for this brand specifically)

Important note: For standard Vitamin B12 deficiency treatment, the IV route generally leads to near-complete urinary excretion of the drug. However, per Methycobal's approved prescribing information (Eisai), both IM and IV are listed as acceptable routes.

Step-by-Step IM Injection Technique

• Methycobal ampoule (500 mcg/1 mL)
• 2-3 mL syringe
• Drawing-up needle (larger gauge, e.g. 21G)
• Injection needle (23G-25G, 1-1.5 inch for IM)
• Alcohol swab / alcowipe
• Gauze / cotton ball
• Sharps disposal bin

• Tap the ampoule top lightly to bring all fluid down.
• Snap open the ampoule at the scored neck (wrap in gauze to protect fingers).
• Inspect the solution - it should be clear, colorless to pale pink. Do not use if cloudy or contains particles.

• Attach the drawing-up needle to the syringe.
• Insert the needle into the ampoule and draw up 1 mL (500 mcg).
• Remove air bubbles by tapping the syringe and gently pushing the plunger.
• Change to the injection needle (smaller gauge).

• Deltoid muscle (upper arm) - good for 1 mL volumes
• Vastus lateralis (outer thigh) - preferred for self-injection
• Ventrogluteal (hip area) - preferred clinical site, safest for deeper IM
• Dorsogluteal (upper outer buttock) - traditionally used but has more risk of nerve injury; less preferred now

• Wipe the chosen site with an alcohol swab in a circular motion.
• Allow to air-dry for 10-15 seconds.

• Spread the skin taut (or use a Z-track technique for gluteal sites to prevent leakage).
• Insert the needle at a 90-degree angle with a swift, firm motion.
• Aspirate (pull back plunger slightly) to confirm you are not in a blood vessel - if blood returns, withdraw and choose a new site.
• Inject slowly and steadily.
• Withdraw needle at the same angle.
• Apply gentle pressure with gauze - do not rub (rubbing can cause local irritation).

• Discard needle and syringe directly into a sharps bin. Never recap the needle.

Dosage

Important Precautions

• Protect from light - Methylcobalamin is light-sensitive. Use immediately after opening and keep the ampoule away from light until administration.
• Do not use if the solution is discolored or has visible particles.
• Rotate injection sites with each dose to prevent local tissue irritation or fibrosis.
• Allergic reactions - although rare, be aware of hypersensitivity. Have the patient wait 10-15 minutes after injection before leaving.
• Pregnancy / breastfeeding - consult a physician before use.
• There is no risk of overdose toxicity as the body excretes excess via urine.

Storage

• Store below 25°C, away from direct light and heat.
• Do not freeze.
• Once opened, use immediately - do not store opened ampoules.

Methycobal IV Injection - Step-by-Step Guide

Preparation

• Methycobal ampoule (500 mcg/1 mL)
• 2-3 mL syringe
• 21G drawing-up needle
• 23G-25G IV needle or butterfly needle (or use an existing IV cannula)
• Alcohol swabs
• Gauze / cotton ball
• Tourniquet (if no IV access in place)
• Gloves
• Sharps bin

Step-by-Step Procedure

• Tap the ampoule to bring all fluid to the bottom.
• Wrap the neck in gauze and snap it open at the scored line.
• Inspect: solution must be clear and colorless to pale pink. Discard if cloudy or particulate.
• Draw up 1 mL (500 mcg) into the syringe using the drawing-up needle.
• Expel all air bubbles.
• Keep the filled syringe covered/shielded from light - methylcobalamin degrades rapidly on light exposure.

• Apply tourniquet to the arm.
• Select a suitable vein (commonly the antecubital fossa or forearm vein).
• Clean the site with an alcohol swab and allow to dry.
• Insert the butterfly needle or IV cannula, confirm blood flashback.
• Release tourniquet.

• Flush the cannula with 2-3 mL normal saline (0.9% NaCl) to confirm patency before injecting.

• Connect the syringe to the needle/cannula port.
• Inject slowly over 1-2 minutes as a direct IV bolus.
• Do not push rapidly - slow administration reduces the risk of vascular irritation.
• Do not dilute in large-volume IV fluids (drip bags) as prolonged exposure to light and fluids degrades the drug.

• Follow with 2-3 mL normal saline flush to clear the cannula of residual drug.

• Remove needle, apply gentle pressure with gauze.
• Dispose of all sharps immediately into the sharps bin.
• Observe the patient for 10-15 minutes for any adverse reaction.

Key Points for IV Administration

Why IV is Less Preferred Over IM

• The patient refuses IM injection
• IM sites are inaccessible (e.g., severe muscle wasting)
• Rapid serum levels are needed

Watch for Adverse Effects

• Local vein irritation or phlebitis (rare)
• Hypersensitivity/anaphylaxis (very rare but possible with any injection)
• Pain at injection site

Paracetamol in Paediatrics - Complete Guide

Golden Rule: Always dose by WEIGHT (mg/kg), not by age alone

1. Oral Route (Most Common)

Standard Dose

• 10-15 mg/kg/dose every 4-6 hours
• Maximum: 4 doses in 24 hours, not exceeding 60 mg/kg/day (max 4 g/day)

Formulations Available

Age-Based Quick Reference (Oral, 15 mg/kg basis)

Under 2 months: Unlicensed - only under specialist supervision.

How to Give Oral Paracetamol

• Use an oral syringe for accurate measurement in infants and young children - never a household spoon.
• Can be given with or without food.
• Shake suspension well before measuring.
• Give directly into the side of the mouth (not the back - risk of choking).

2. Intravenous (IV) Route

IV Paracetamol Doses (Perfalgan / IV Infusion)

How to Give IV Paracetamol

• IV paracetamol comes as 10 mg/mL (e.g., 1 g in 100 mL, or can be prepared as weight-based smaller volumes for children).
• For children under 10 kg, withdraw the required volume (1 mL/kg = 10 mg/kg) from the vial.
• Inspect for clarity before use.

• Give via a volumetric infusion pump - never by free flow or IV push.
• Infuse over 15 minutes (standard infusion time for IV paracetamol).
• Use a dedicated IV line or flush before and after with normal saline.
• Monitor weight carefully - double-check the dose before programming the pump.

Critical safety: IV paracetamol 10-fold overdose errors have been reported in children when 1 g/100 mL adult vials are used for small children. Always verify the volume being infused is correct for the child's weight.

3. Rectal Route (PR)

Rectal Dose

How to Give Rectal Paracetamol (Suppository)

• Wash hands and wear gloves.
• Position child on their side (left lateral) with knees slightly bent.
• Unwrap the suppository.
• Gently part the buttocks and insert the suppository pointed end first into the rectum, just past the sphincter (about 2-3 cm in small children).
• Hold the buttocks together gently for 1-2 minutes to prevent expulsion.
• If the suppository is expelled within 15 minutes, a replacement dose can be given.

Note: Rectal absorption is slower and more variable than oral. Not recommended in neonates under 32 weeks gestation.

4. Special Situations

5. Key Safety Points

• Never exceed 60 mg/kg/day (or 4 g/day, whichever is less).
• Do not combine with other paracetamol-containing products (e.g., combination cold syrups).
• Signs of overdose: Nausea, vomiting, abdominal pain - can lead to liver failure if untreated. Treat with N-acetylcysteine (NAC).
• Always use a calibrated oral syringe - not a kitchen teaspoon.
• Recheck weight at each visit for ongoing prescriptions in young children, as dosing needs to be adjusted as the child grows.

Can ORS Be Given to a Hypertensive Patient with Diarrhea?

Short Answer: Yes, but with caution and monitoring.

The Concern - Sodium Content of ORS

Why ORS is Still Generally Safe (and Often Necessary)

1. Dehydration is the bigger immediate threat. Active diarrhea causes rapid fluid and electrolyte loss. Untreated dehydration can cause:
   • Hypovolemia and hypotension
   • Reflex activation of the renin-angiotensin system - which worsens hypertension long-term
   • Acute kidney injury (especially in patients on antihypertensives like ACE inhibitors/ARBs/diuretics)
2. ORS is a treatment dose, not a dietary supplement. The sodium in ORS replaces what is being lost through diarrhea - it is not a net gain. The body is losing sodium in the stool; ORS simply replaces it.
3. WHO reduced-osmolarity ORS (75 mmol/L sodium) is much safer than the original formulation and is now the global standard.

When ORS Should Be Used Cautiously or Avoided

Practical Recommendations

For a hypertensive patient with mild-to-moderate diarrhea and dehydration:

• Give ORS - the benefit of treating dehydration outweighs the sodium risk.
• Use WHO reduced-osmolarity ORS (75 mmol/L sodium).
• Give in small, frequent sips rather than large boluses.
• Monitor blood pressure during treatment.
• Continue antihypertensive medications (do not stop them).

For a hypertensive patient on diuretics:

• Be especially vigilant - diuretics already cause fluid/electrolyte loss. Diarrhea on top of this can cause severe dehydration and electrolyte imbalance.
• ORS is actually more important in this group to replace electrolytes.
• Watch for hypokalemia (both diarrhea and diuretics deplete potassium).

For a hypertensive patient with heart failure or renal failure:

• ORS is relatively contraindicated.
• Refer for IV fluid management under monitoring.

Key Points Summary